Investigations into deviations, reports, and/or follow-up actions were inadequate.
Inspection Record
Amorepacific Canada Inc — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The master production documents were inadequate.
The quality control department did not evaluate the results of the annual product quality review.
The examination and/or approval of fabrication, packaging, labelling, testing, storage, and/or the transportation method and procedures by the person in charge of the quality control department before implementation was inadequate.
The training of personnel in good manufacturing practices and/or the maintenance of records was inadequate.
The evidence used to demonstrate the transportation and/or storage conditions of each lot or batch of the drug was inadequate.
Deficiencies were noted with the procedure for the assessment of returned drugs being considered for resale.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Pharmaris Canada Inc.2023-01-19 · Health CanadaSimilar to finding 3 The quality control department did not evaluate the results of the annual product quality review.
- 10445517 Canada Inc / North Pharmaceuticals / DAC Pharmaceuticals2025-03-13 · Health CanadaSimilar to finding 3 The quality control department did not evaluate the results of the annual product quality review.
- Bonita Pharmaceuticals Inc.2026-08-13 · Health CanadaSimilar to finding 1 Investigations into deviations, reports, and/or follow-up actions were inadequate.
- Boehringer Ingelheim (Canada) Ltd Ltee2025-03-03 · Health CanadaSimilar to finding 3 The annual product quality review procedure was inadequate. The quality control department did not evaluate the results of the annual product quality review.
- Prometic Bioproduction Inc. dba Kedrion Biopharma Canada2026-09-01 · Health CanadaSimilar to finding 1 Investigations into deviations, reports, and/or follow-up actions were inadequate.
A record as of the Health Canada inspection on 2026-07-28. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.